| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/06/2005 | CN1195863C Retroviral vectors |
| 04/06/2005 | CN1195862C Isolated and purified nucleic acids comprising a gene specifically expressed in hop glands |
| 04/06/2005 | CN1195857C Multiply-substituted protease variants |
| 04/06/2005 | CN1195856C 启动子 Promoter |
| 04/06/2005 | CN1195853C Neurotrophic factor NNT-1 |
| 04/06/2005 | CN1195849C APPIL-a novel protein with growth effects |
| 04/06/2005 | CN1195844C Avian primordial germ cell (PGC) cell line and method for long term culturing thereof |
| 04/06/2005 | CN1195777C Novel insulin derivatives having rapid onset of action |
| 04/06/2005 | CN1195774C HEV antigenic peptide and its method |
| 04/06/2005 | CN1195769C Natural antitumor or antiviral substances and use of the same |
| 04/05/2005 | US6875908 Soybean cultivar 926877 |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |
| 04/05/2005 | US6875845 Polypeptide for use in the treatment of cancer |
| 04/05/2005 | US6875844 Recombinant or chemically synthesized intestinal carboxyesterase (ICE)amino acid sequences for treating solid tumors |
| 04/05/2005 | US6875741 Insulin and IGF-1 receptor agonists and antagonists |
| 04/05/2005 | US6875608 Generating progenitor cells in culture; models for diagnosis, prevention and treatment of cancer |
| 04/05/2005 | US6875607 Embryonic stem cells |
| 04/05/2005 | US6875606 Human α-7 nicotinic receptor promoter |
| 04/05/2005 | US6875605 Seeding and propagating tissue on three-dimensional nonwoven fibrous matrix of polyethylene terephthalate; tissue engineering |
| 04/05/2005 | US6875600 Mixed cell diagnostic systems |
| 04/05/2005 | US6875599 Enzymatic protein for use in the treatment of inflammation, cancers, cardiovascular, brain, respiratory and crohn's disease |
| 04/05/2005 | US6875597 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 04/05/2005 | US6875592 Methods for the detection, analysis and isolation of nascent proteins |
| 04/05/2005 | US6875588 Ovomucoid promoter and methods of use |
| 04/05/2005 | US6875581 Identifying agonist and/or antagonist of calcium calmodulin-dependent protein kinases using laser fluctuation correlation spectroscopy; peptide mimetics; immunosuppressants |
| 04/05/2005 | US6875580 Hybridoma cell line which produces monoclonal antibody for isolation and identification of a subset of antigen presenting cells; immunostaining and immunohistochemistry |
| 04/05/2005 | US6875578 Detect of toxins in sample; obtain cells, incubate with test compound, scan cells, detect and quantify signal, presence of signal indicate presence of toxin |
| 04/05/2005 | US6875576 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | US6875442 Process for growing tissue in a biocompatible macroporous polymer scaffold and products therefrom |
| 04/05/2005 | US6875441 Composition for delivery of hematopoietic growth factor |
| 04/05/2005 | US6875430 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 04/05/2005 | CA2276146C Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 04/05/2005 | CA2207757C Breast tissue engineering |
| 04/05/2005 | CA2161798C Animal model for hepatitis virus infection |
| 04/05/2005 | CA2142308C Dna sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants |
| 04/05/2005 | CA2116449C Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 04/03/2005 | CA2444292A1 Bipotential liver cell lines from wild-type mammalian liver tissue |
| 03/31/2005 | WO2005028667A1 Drug targeting g protein-coupled receptor expressed in human mast cells and method of screening the same |
| 03/31/2005 | WO2005028655A1 A method for increasing the efficiency of transgenic animal production |
| 03/31/2005 | WO2005028652A1 Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene |
| 03/31/2005 | WO2005028642A2 Method of culturing cells including the inhibition of the expression of a gene or genes involved in cell cycle control |
| 03/31/2005 | WO2005028641A1 Method for production of neurons from cells of a cell line |
| 03/31/2005 | WO2005028640A1 Method for isolating hepatocytes |
| 03/31/2005 | WO2005028639A2 Environments that maintain function of primary liver cells |
| 03/31/2005 | WO2005028638A1 Composition for coating support for preparation of cell sheet, support for preparation of cell sheet and process for producing cell sheet |
| 03/31/2005 | WO2005028626A2 Cell culture media |
| 03/31/2005 | WO2005028625A2 Consensus/ancestral immunogens |
| 03/31/2005 | WO2005028619A2 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof |
| 03/31/2005 | WO2005028509A1 Tlr2 antagonistic antibody and use thereof |
| 03/31/2005 | WO2005027841A2 Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease |
| 03/31/2005 | WO2005027634A1 Apparatus and methods for selecting capacitated spermatozoa and uses thereof |
| 03/31/2005 | WO2005027633A2 Methods and compositions for the cryopreservation of organs |
| 03/31/2005 | WO2005016283A3 Peptides for enhanced cell attachment and growth |
| 03/31/2005 | WO2005001076A3 Postpartum cells derived from placental tissue, and methods of making and using the same |
| 03/31/2005 | WO2004113512A3 Method of generating islet beta-cells from exocrine pancreatic cells |
| 03/31/2005 | WO2004101772A3 Neural cells |
| 03/31/2005 | WO2004100870A3 Compositions and methods for wt1 specific immunotherapy |
| 03/31/2005 | WO2004087736A3 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 03/31/2005 | WO2004084838A3 Identification, quantification, and characterization of t cells and t cell antigens |
| 03/31/2005 | WO2004083406A3 Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
| 03/31/2005 | WO2004058305A3 Encapsulated cell for therapy |
| 03/31/2005 | WO2004053084A3 Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases |
| 03/31/2005 | WO2004048325A3 Modulation of jagged 1 expression |
| 03/31/2005 | WO2004039234A3 Humanized antibodies against the venezuelan equine encephalitis virus |
| 03/31/2005 | WO2004031276A3 Method of inducing maturation of dendritic cells and uses therefor |
| 03/31/2005 | WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2005 | WO2003018756A3 Methods for preparing purified prostaglandin e synthase |
| 03/31/2005 | WO2002099054A3 Hccss as modifiers of the p53 pathway and methods of use |
| 03/31/2005 | US20050071899 Nucleotide sequences comprising stilbene synthase regulatory region for use as tool in enhancing ozone resistance in plants; improving crop yields; delaying senescence |
| 03/31/2005 | US20050071897 Nucleotide sequences coding gibberellin insensitive (GAI) polypeptides for use in transformation and generation of lodge resistant dwarf plants; enhancing crop yields |
| 03/31/2005 | US20050071890 Using vector transformation to generate cell comprising a nd expressing malarial merozoite surface protein (MSP-1) gene sequences; vaccine development and drug screening |
| 03/31/2005 | US20050070874 System and method for injecting liquid drug containing biological material |
| 03/31/2005 | US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders |
| 03/31/2005 | US20050070695 Expression vector comprising nucleotide sequences coding modified cholesterol binding toxin for use as tool in generating vaccine to prevent microorganismal infection; genetic vaccines; bactericides; immunotherapy |
| 03/31/2005 | US20050070692 Anti-interleukin-1 beta analogs |
| 03/31/2005 | US20050070691 Polypeptides of moraxella (branhamella) catarrhalis |
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050070493 Methods and compositions for treating Parkinson's disease |
| 03/31/2005 | US20050070463 membrane proteins associated with LPSs (lipopolysaccharides), for inducing maturation of dendritic cells; membrane fraction has a proteoglycan titer, represented by the sum of the contents of galactose and of proteins, between 1.2 g/l - 3.4 g/l for galactose and between 7.5 g/l - 14.9 g/l for proteins |
| 03/31/2005 | US20050070015 Methods of controlling proliferation of cancer cells and cell death |
| 03/31/2005 | US20050070014 Method of expressing foreign gene in kidney |
| 03/31/2005 | US20050070013 Restricted glucose feed for animal cell culture |
| 03/31/2005 | US20050070005 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 03/31/2005 | US20050070002 Histidine phosphatase interacting protein with 120kd |
| 03/31/2005 | US20050069988 Recombinant expression systems for production of low solubility foreign proteins specifically aminoglobulin |
| 03/31/2005 | US20050069985 Assay methods and amelioration of muscular dystrophy symptoms |
| 03/31/2005 | US20050069984 Identification of sortase gene |
| 03/31/2005 | US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders |
| 03/31/2005 | US20050069982 Using major histocompatibility complex class I receptor peptide binding cleft as tool in identifying cleavage recognition site of polypetide; tissue targeted therapy; immunotherapy |
| 03/31/2005 | US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents |
| 03/31/2005 | US20050069979 Cell culture process |
| 03/31/2005 | US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/31/2005 | US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing |
| 03/31/2005 | US20050069943 101 human secreted proteins |
| 03/31/2005 | US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 03/31/2005 | US20050069922 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus |
| 03/31/2005 | US20050069896 Rb pathway and chromatin remodeling genes that antagonize let-60 Ras signaling |
| 03/31/2005 | US20050069883 Melanin-concentrating hormone receptor antagonist binding protein |